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A B S T R A C T
Whilst elevations in basal cortisol levels have been reported among individuals at-risk for psychosis, the extent to
which this represents hyperresponsivity of the hypothalamic-pituitary-adrenal (HPA) axis to psychosocial
stressors encountered in the natural environment is currently unclear. We aimed to examine stressor-cortisol
concordance among youth at clinical high-risk (CHR) for psychosis in the North American Prodrome
Longitudinal Study 2 (NAPLS 2) and the relationship with clinical outcome. At baseline, CHR (N=457) and
healthy (N=205) individuals provided salivary cortisol samples and completed daily stressor, life event, and
childhood trauma measures. CHR youth were categorised as remitted, symptomatic, progression of positive
symptoms, or psychosis conversion at the two-year follow-up. Within-group regression models tested associa-
tions between psychosocial stressors and cortisol; standardised beta coefficients (Stβ) were subsequently derived
to enable within-group pooling of effect sizes across stressor types. After adjustment for potential confounders,
all CHR subgroups reported greater exposure to life events and daily stressors, and more distress in relation to
these events, relative to controls. All CHR groups were also more likely to experience childhood trauma; only
CHR converters, however, were characterised by elevated basal cortisol. Daily stressor distress was significantly
associated with cortisol in controls (β=0.60, 95% CI: 0.12–1.08) and CHR youth who converted to psychosis
(β=0.91, 95% CI: 0.05–1.78). In controls only, life event exposure was associated with cortisol (β=0.45, 95%
CI: 0.08–0.83). When pooled across stressors, stressor-cortisol concordance was substantially higher among CHR
converters (Stβ=0.26, 95% CI: 0.07 to 0.44) relative to CHR progressed (Stβ=0.02, 95% CI: -0.11 to 0.15),
symptomatic (Stβ=0.01, 95% CI: -0.11 to 0.12), and remitted groups (Stβ=0.00, 95% CI: -0.13 to 0.13);
however, unexpectedly, healthy controls showed intermediate levels of concordance (Stβ=0.15, 95% CI: 0.05
to 0.26). In conclusion, whilst all CHR subgroups showed increased psychosocial stress exposure and distress
relative to controls, only those who later converted to psychosis were characterised by significantly elevated
basal cortisol levels. Moreover, only CHR converters showed a higher magnitude of stressor-cortisol concordance
compared to controls, although confidence intervals overlapped considerably between these two groups. These
findings do not support the notion that all individuals at CHR for psychosis show HPA hyperresponsiveness to
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T
psychosocial stressors. Instead, CHR individuals vary in their response to stressor exposure/distress, perhaps
driven by genetic or other vulnerability factors.
1. Introduction
Originally formulated over twenty years ago, and recently updated,
the neural diathesis-stress model proposes that the hypothalamic-pi-
tuitary-adrenal (HPA) axis is the central physiological mechanism
linking psychosocial stress to the onset and exacerbation of schizo-
phrenia and related psychotic disorders (Pruessner et al., 2017; Walker
et al., 2008; Walker and Diforio, 1997). A central tenet to this model is
that individuals with increased vulnerability for psychosis are more
sensitive to the effects of psychosocial stressors due to abnormalities
within the HPA axis (e.g., HPA hyperactivity/dysregulation or in-
creased glucocorticoid sensitivity) which in turn contribute to dopa-
minergic and glutamatergic abnormalities that eventually trigger ex-
pression of psychotic illness (Pruessner et al., 2017). In support of the
model, accumulated evidence indicates that patients with psychosis
exhibit elevated basal cortisol relative to healthy controls (Borges et al.,
2013; Girshkin et al., 2014; Hubbard and Miller, 2019), but a blunted
cortisol awakening response [CAR (Berger et al., 2016; Borges et al.,
2013)], the latter thought to represent a distinct HPA axis component,
independent of stress-induced cortisol secretion (Boehringer et al.,
2015). More recently, these features have been reported among in-
dividuals who are at increased risk for psychosis due to clinical features
and/or genetic liability (Chaumette et al., 2016; Cullen et al., 2014b;
Day et al., 2014; Mittal et al., 2007; Walker et al., 2001; Yildirim et al.,
2011). Moreover, at-risk individuals who later develop full psychosis
show even greater increases in basal cortisol (Walker et al., 2010;
Walker et al., 2013) and pituitary volume (Saunders et al., 2019),
suggesting that increased HPA axis activity may signal risk for wor-
sening illness.
In parallel with this research, studies show that at-risk individuals
report greater exposure and sensitivity to a range of psychosocial
stressors, including major life events, childhood trauma, and minor
daily stressors (Cullen et al., 2014a; Fusar-Poli et al., 2017; Kelleher
et al., 2008; Mayo et al., 2017; Myin-Germeys et al., 2001; Palmier-
Claus et al., 2012; Peh et al., 2019; Tessner et al., 2011; Trotman et al.,
2014). However, there has been a paucity of studies examining the
concordance between psychosocial stressor exposure/distress and HPA
axis function; as such, the extent to which individuals on the psychosis
spectrum exhibit ‘abnormal’ HPA axis responses to psychosocial stres-
sors is unclear. That is, the increases in basal cortisol observed in those
with, and at-risk for, psychosis may represent either (a) a ‘normal/
adaptive’ response to the high levels of psychosocial stressors reported
in these populations (i.e., concordance being similar to healthy in-
dividuals), or (b) hyperresponsivity of the HPA axis (perhaps due to
genetic or early life factors), characterised by an increase in cortisol
greater than that expected in a healthy individual (i.e., increased con-
cordance). Alternatively, the elevated basal cortisol levels observed
may be partially independent of psychosocial stress exposure/distress
(i.e., no concordance), and instead reflect individual-level factors such
as genetic predisposition to HPA axis hyperactivity (Hartling et al.,
2019; Pagliaccio et al., 2015; Starr et al., 2019) or metabolic abnorm-
alities (e.g., glucose metabolism, which is regulated by the HPA axis),
the latter being more common among individuals at clinical high-risk
(CHR) for psychosis (Cadenhead et al., 2019), who present features
consistent with the prodromal phase of illness.
Two recent studies of at-risk individuals support the ‘increased
concordance’ hypothesis: Using the experience sampling method, sib-
lings of psychosis patients showed more pronounced increases in sali-
vary cortisol in response to unpleasant events relative to controls
(Collip et al., 2011), whilst a further study reported a stronger
association between retrospectively-reported stressful life events and
basal cortisol in CHR youth compared to controls (Labad et al., 2015).
In contrast, lower (i.e., blunted) cortisol responses during psychosocial
stressor tasks have observed in CHR individuals (Pruessner et al., 2013)
and young adults with high schizotypy traits (Walter et al., 2018) re-
lative to controls; a pattern consistent with that observed in patients
with chronic schizophrenia (Zorn et al., 2017). Together, these findings
tentatively suggest that naturally-occurring psychosocial stressors are
associated with greater cortisol increases in at-risk individuals com-
pared to healthy controls, whereas the response to experimentally-in-
duced psychosocial stressors is blunted. However, the degree to which
HPA axis responses to laboratory-based stressor tasks (which have low
ecological validity) are relevant to psychosis aetiology is unclear.
Studying the effect of naturally-occurring stressors on HPA axis
function is methodologically complex. Unlike studies using experi-
mentally-induced stressor tasks, the lapse of time between stressor ex-
posure and cortisol measurement may be considerable. Whilst eleva-
tions in cortisol levels following stressor exposure appear to decrease
over time (Miller et al., 2007), early life events and trauma exposure are
associated with HPA dysregulation later in life, suggesting long term
effects of stress exposure (Pruessner et al., 2017; Walker et al., 2008;
Walker and Diforio, 1997). A related issue is that stress measures and
cortisol samples may not be collected on the same day, particularly
when studies have large assessment batteries spanning several days. It
is possible that day-to-day variations in perceived stress might influence
both retrospective reporting of stressful events (and associated distress)
and cortisol levels, such that greater concordance is observed when
measures are collected on the same day. However, to our knowledge,
this has yet to be investigated.
Determining the extent to which HPA axis responsivity in at-risk
youth predicts clinical outcome is important, as such work might ulti-
mately help to identify individuals at increased risk of illness progres-
sion by virtue of being more sensitive to the effects of psychosocial
stress, enabling targeted interventions. Utilising data from the North
American Prodrome Longitudinal Study 2 [NAPLS 2, (Addington et al.,
2012)] we investigated whether psychosocial stressors, basal cortisol
levels, and stressor-cortisol concordance (i.e., the magnitude of asso-
ciation between psychosocial stressors and cortisol) at the baseline as-
sessment differed across healthy controls and CHR subgroups defined
on the basis of their clinical presentation at the two-year follow-up
(remitted, symptomatic, progression of positive symptoms, and con-
verted to psychosis). Based on previous studies, we hypothesised that
CHR youth who later converted to psychosis would show (a) greater
exposure and distress in relation to psychosocial stressors, (b) elevated
basal cortisol, and (c) higher stressor-cortisol concordance relative to
healthy controls; we also anticipated that CHR non-converters would be
intermediate to CHR converters subgroups and healthy controls (i.e.,
converters > positive symptom progression > symptomatic >
remitted > controls) on these measures. In all analyses we controlled
for a range of potential confounders (age, sex, medication exposure, and
cannabis use), and additionally explored the effect of lapse-of-time
between assessments on stressor-cortisol concordance.
2. Materials and Methods
2.1. Sample
NAPLS 2 is a consortium of eight research sites examining CHR
youth, the aims and recruitment methods for which are detailed else-
where (Addington et al., 2012). Briefly, CHR subjects were help-seeking
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individuals who met criteria for one or more prodromal syndromes: (a)
attenuated psychotic symptoms; (b) brief intermittent psychotic
symptoms; or (c) substantial functional decline combined with a first-
degree relative with a psychotic disorder, or schizotypal personality
disorder in individuals younger than 18 years. Prodromal syndromes
were assessed using the Criteria of Prodromal Syndromes (COPS), based
on the Structured Interview for Prodromal Syndromes [SIPS
(McGlashan et al., 2010)], conducted by clinically-trained interviewers;
psychiatric diagnoses were determined via the Structured Clinical In-
terview (SCID) for DSM-IV (First et al., 1995). CHR individuals who had
met criteria for an Axis I psychotic disorder were not eligible for in-
clusion; treatment with antipsychotic medication was permitted pro-
vided that full psychotic symptoms were not present at the time of
medication commencement. Healthy controls (HC) were recruited from
the community and had no personal history or first-degree relative with
psychosis and did not meet criteria for any prodromal syndrome. All
participants were aged between 12 – 35 years at recruitment. Exclusion
criteria for both groups included substance dependence in the past six
months, neurological disorder, or full-scale IQ < 70. Non-psychotic
psychiatric disorders were permitted in CHR and healthy control groups
(Addington et al., 2017).
2.2. Procedure
Ethical approval was provided by Institutional Review Boards at
each NAPLS site (Addington et al., 2012), all participants provided
informed consent or assent. The current sample includes 662 partici-
pants for whom variables of interest at baseline (salivary cortisol and at
least one of the stress measures examined in the current study) and
clinical status at follow-up were available. At baseline, participants
provided information on sociodemographic factors and potential con-
founders, completed stress measures, and collected saliva samples.
Baseline assessments were completed over two or more visits. Where
possible, saliva was collected on the same day as daily stressor, life
event and childhood trauma measures (achieved in 50%, 40%, and 38%
of cases, respectively). However, in some in cases (16%), the baseline
assessment was interrupted (e.g., due to clinical crises or other life
changes) that lead to a substantial delay (> 2 months) in the comple-
tion of all measures. In such instances, the remaining baseline measures
were collected when the participant was able to return and complete
the schedule, with clinical assessments repeated to confirm CHR status.
All participants were included in the analysis which accounted for time-
lapse between assessments. Prodromal symptoms were assessed via the
SIPS at 12- and 24-month follow-up assessments and used to categorise
CHR subgroups [see Table 1 for details (Addington et al., 2019; Walker
et al., 2013)].
2.3. Sociodemographic factors and potential confounders assessed at
baseline
Participant date of birth, sex, and ethnicity were assessed via self-
report, the latter was subsequently collapsed to a four-level variable
(white, black African/African Caribbean, Asian/Middle Eastern, other).
Cannabis use was assessed via a structured interview (Buchy et al.,
2015). For the purposes of the current investigation we created a binary
variable indexing current use (no/yes). Details of all prescribed psy-
chotropic medications (type, name, dosage, and frequency) were ob-
tained at the baseline assessment via self-report, pharmacy records,
and/or medical records. Binary variables (no/yes) were created for
current antipsychotic use and current psychotropic use (non-anti-
psychotics), irrespective of type, dose, or data source.
2.4. Stress measures
The 58-item, Daily Stress Inventory (Brantley et al., 1987), was used
to determine the presence of minor stressors (e.g., ‘Performed poorly at
task’, ‘Was ignored by others’) occurring within the past 24 -hs. Parti-
cipants indicated whether they experienced each stressor and the level
of distress elicited by each endorsed stressor (scored on a 7-point scale:
1 ‘occurred but was not stressful’ to 7 ‘caused me to panic’). Total
distress scores (range: 0-406) were then divided by the total exposure
score (range: 0-58) to obtain an average distress per item score (range:
0-7).
Life events (e.g., ‘End of romantic relationship’, ‘Loss of job’) were
assessed via the Psychiatric Epidemiology Research Interview Life
Events Scale (Dohrenwend et al., 1978), modified to exclude life events
of lesser relevance to youth (e.g., divorce and financial losses) (Trotman
et al., 2014). The 59 events can be classified as independent or de-
pendent (of an individual’s influence/behaviour). Interviewers re-
corded how often each of the 59 events had occurred in the partici-
pant’s lifetime and the associated level of distress (scored using the
same 7-point scale described above); participants could report multiple
exposures to the same event (distress on each occasion also recorded),
where the maximum occurrence for any single life event in the NAPLS
cohort was four. An average life event distress score (range: 0-7) was
derived by dividing the total distress score (potential range: 0-1652) by
the total exposure score (potential range: 0-236).
Participants additionally completed the Childhood Trauma and
Abuse Scale (Janssen et al., 2004), a semi-structured interview ex-
amining experiences of physical, sexual, and psychological abuse, and
emotional neglect, occurring prior to age 16 (Addington et al., 2013).
Each trauma type was scored as absent/present with a binary variable
indexing any form of trauma derived.
2.5. Salivary cortisol
At the research session, participants provided three saliva samples
(one per hour) with a mean salivary cortisol value subsequently derived
when two or more samples were available (participants with only one
sample were excluded). The median time of collection for the three
samples was 1107 h (range: 0615-1811), 1207 h (range: 0645-1956),
and 1300 h (range: 0715-1946), respectively. The mean cortisol value,
which is highly correlated with area under the curve (AUC) values
(Walker et al., 2010), was computed to provide consistency with pre-
vious publications (Walker et al., 2013). Participants were instructed to
avoid consumption of caffeine, alcohol, or dairy products after 1900 h
on the day before sampling; individuals who reported non-compliance
with these instructions were not excluded as previous analyses per-
formed on a subset of the cohort found no association with these
variables and cortisol levels (Walker et al., 2013). Use of non-
Table 1
Categorization of clinical high-risk subgroups at the two-year follow-up.
CHR subgroup Definition
Remitted All SIPS positive symptoms rated ≤ 2
Symptomatic One or more SIPS positive symptoms present in the past 4 weeks, rated 3-5, but with no increase in the past year
Progression of positive symptoms CHR criteria met with one or more SIPS positive symptoms rated 3-5 and increasing in severity
Converted A rating of 6 on one or more SIPS positive symptoms
SIPS: Structured Interview for Prodromal Syndromes. Outcome status was determined using information from the final follow-up assessment (in most instances, the
24-month follow-up) with the exception that individuals classified as converters at any follow-up assessment were not reclassified if their symptoms later remitted.
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prescription medications (corticosteroids, antihistamines, diet pills,
cough/cold medicine) over the past 24 hours was assessed via self-re-
port. Samples were stored at -20 °C, and rapidly thawed and centrifuged
prior to assay using a highly sensitive enzyme immunoassay (Sali-
metrics, State College, Pennsylvania). All samples were assayed in du-
plicate with intra- and inter-assay coefficients of variation less than
10% and 15%, respectively.
2.6. Data analyses
All analyses were performed using Stata Version 15 (StataCorp,
2017). The number of days between stress measure completion and
cortisol collection could not be computed for∼6% of the sample due to
missing assessment dates. In such cases, missing values for the three
time-lapse variables were imputed using the median number of days
(daily stressor and cortisol = 0 days, life events and cortisol= 1 day,
childhood trauma and cortisol = 2 days) across the entire sample. The
imputed data variables were used in all subsequent analyses.
Ladder and gladder commands were used to identify transforma-
tions yielding normally distributed continuous variables. Subsequently,
age, cortisol, daily stressor average distress scores, and life event ex-
posure scores were log-transformed, daily stressor exposure scores were
square-root transformed, whilst life event average distress scores did
not require transformation. There were no transformations that could
improve the distribution of the assessment time-lapse variable, there-
fore a five-level categorical variable was created (1) cortisol collected
before stress measurement; (2) assessments completed on the same day;
(3) cortisol 1-10 days after stress measurement; (4) cortisol 11-30 days
after; and (5) cortisol> 30 days after). Next, we examined correlations
between salivary cortisol and sampling variables, namely, time of first
sample collection, number of samples collected (two only vs. all three),
and use of non-prescription medications in past 24 hours. To remove
the influence of relevant factors (those associated with cortisol at the
p < 0.05 level), cortisol values for the entire sample were regressed on
sampling time, cough/cold medication use, and corticosteroid use to
obtain standardised residuals. The resulting (normally distributed)
variable was used for all subsequent analyses.
Group differences in demographic variables were examined using
one-way analysis of variance, Kruskall Wallis, and chi-squared tests. To
identify potential confounders, associations among demographic fac-
tors, cortisol, and psychosocial stress measures were examined using
within-group Pearson’s correlations (for continuous - continuous pair-
ings), biserial correlations (for continuous - categorical pairings), and
chi-squared tests (for categorical - categorical pairings). Associations of
group status with basal cortisol and psychosocial stressors were next
examined, with adjustment for factors that were found in the above
steps to be significantly associated with basal cortisol and/or any
stressor in any group. Analyses of covariance (ANCOVA), were em-
ployed for basal cortisol and continuous stressor measures, with esti-
mated means and standard errors (SE) derived from these models. For
trauma exposure, a logistic regression model was used to test the as-
sociation with group status (testparm command); pairwise comparisons
and adjusted trauma prevalence rates and associated SEs for each group
were derived from the logistic model. All pairwise comparisons were
performed with Sidak correction for multiple testing.
To test whether stressor-cortisol concordance was moderated by
time-lapse between assessments, correlations between cortisol and
psychosocial stressors were examined within each time-lapse category.
Linear regression models were used to test associations between in-
dividual psychosocial stressors (predictor variables) and salivary cor-
tisol (outcome variable) in each group. Owing to multicollinearity, each
stressor was examined in a separate model; all models were adjusting
for potential confounders identified in the above steps. To facilitate
comparison of stressor-cortisol concordance across groups, from these
adjusted models, we obtained standardised beta coefficients (Stβ) for
each psychosocial stress measure and computed SEs for these coeffi-
cients [SEStβ = SEβ (Stβ/β)]. Stβ coefficients for each stressor were
then pooled using the ‘meta’ command (random effects) to obtain an
overall measure of stressor-cortisol concordance.
Table 2
Sample Characteristics at Baseline Assessment by Follow-up Status.
Healthy Controls
(n= 205)
CHR Remitted
(n= 134)
CHR Symptomatic
(n= 130)
CHR Progressed
(n=124)
CHR Converted
(n= 69)
Test p
Age (years); mean (SE)
1
20.33 (0.33) 18.31 (0.39) 19.55 (0.38) 19.51 (0.43) 18.52 (0.44) F=5.04a 0.001
Sex (female); n (%) 101 (49.3) 62 (46.3) 55 (42.3) 50 (40.3) 27 (39.1) χ2=3.99 0.407
Ethnicity; n (%)
White 113 (55.1) 77 (57.5) 72 (55.4) 70 (56.5) 35 (50.7) χ2=9.97 0.619
Black African/Caribbean 37 (18.1) 19 (14.2) 30 (23.1) 19 (15.3) 11 (15.9)
Asian/Middle Eastern 23 (11.2) 12 (9.0) 8 (6.2) 9 (7.3) 9 (13.0)
Other2 32 (15.6) 26 (19.4) 20 (15.4) 26 (21.0) 14 (20.3)
Current antipsychotic use;
n (%)
0 (0.0) 23 (17.4) 18 (13.9) 13 (10.7) 12 (17.4) χ2=36.66a,b,c,d <0.001
Current psychotropic use; n
(%)3
2 (1.0) 46 (34.8) 48 (36.9) 36 (30.0) 20 (29.0) χ2= 83.33a,b,c,d 0.001
Cannabis use ever: n (%) 85 (41.5) 64 (48.1) 76 (58.5) 76 (61.3) 40 (58.8) χ2=17.61b,c,d,f 0.001
No. days between
assessments; median
(IQR)4
Cortisol and daily stressors 0 (14) 0 (14) 0 (6) 0 (14) 0 (7) KW χ2=5.47 0.243
Cortisol and life events 1 (21) 1 (15) 0 (9) 1 (20) 1 (9) KW χ2=4.68 0.321
Cortisol and trauma 2 (24) 1 (15) 2 (13) 6 (22.5) 3 (19) KW χ2=8.48 0.076
CHR: Clinical high-risk; IQR: interquartile range; KW: Kruskal Wallis (with adjustment for ties).
1Descriptive statistics provided for raw (untransformed) age variable with statistical tests performed on log-transformed variable.
2Includes First Nations, Central/South American, Native Hawaiian or Pacific Islander, and interracial.
3Includes any non-antipsychotic psychotropic medication.
4Represents imputed variable (missing data replaced with sample median).
Missing data: current antipsychotic use (n=7); current psychotropic use (n=7). Bold font indicates p< 0.05 for effect of group status. Pair-wise comparisons
p< 0.05: a Controls vs. CHR Remitted; b Controls vs. CHR Symptomatic; c Controls vs. CHR Progressed; d Controls vs. CHR Converted; e CHR Remitted vs. CHR
Symptomatic; f CHR Remitted vs. CHR Progressed; g CHR Remitted vs. CHR Converted; h CHR Symptomatic vs. CHR Progressed; i CHR Symptomatic vs. CHR
Converted; j CHR Progressed vs. CHR Converted.
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3. Results
3.1. Sociodemographic characteristics
Of the 457 CHR individuals included in the current study, 134
(29.3%) showed a remission of CHR symptoms, 130 (28.4%) remained
symptomatic, 124 (27.1%) experienced a progression of positive
symptoms, and 69 (15.1%) converted to psychosis. The groups did not
differ on sex or ethnicity (Table 2); however, there was a relation of
follow-up status with age (F2,726 = 5.04, p = 0.001), with post-hoc
tests indicating that CHR individuals whose symptoms remitted were
significantly younger than controls at baseline. Group status was sig-
nificantly associated with both antipsychotic use (χ2=36.66,
p<0.001) and any other psychotropic use (χ2= 83.33, p = 0.001) at
baseline; in both cases, individual chi-squared tests indicated that all
four CHR groups were more likely to be treated with medication re-
lative to controls but did not differ from each other. The same pattern
was observed for cannabis use, whereby a significant overall association
was observed between current use and group status (χ2=17.61, p =
0.001) with individual tests showing that current cannabis use was
more common among all CHR groups relative to controls but that the
prevalence did not differ across CHR subgroups. Non-parametric
Kruskal Wallis (KW) tests performed on the continuous time-lapse
variable indicated that the groups did not differ on the lapse-of-time
between cortisol collection and daily stressor assessment (KW χ2=
5.47, p= 0.243), cortisol collection and life event assessment (KW χ2=
4.68, p = 0.321), or cortisol collection and trauma assessment (KW
χ2= 8.48, p = 0.076).
3.2. Potential confounders
Age was positively associated with life event exposure and life event
distress in controls and all four CHR groups, with daily stressor distress
in CHR remitted, symptomatic, and progressed groups, and with cor-
tisol in controls, CHR remitted, and CHR converted groups (p < 0.05
for all). Female sex was likewise positively associated with life event
exposure in controls, daily stressor exposure in the CHR remitted group,
daily stressor distress in CHR symptomatic individuals, and with all five
psychosocial stressor measures in the CHR progression of positive
symptoms group. In contrast, ethnicity (recoded as white vs. non-white)
was not associated with any stress measure or cortisol in any group.
With regards to psychotropic medication, antipsychotic use at baseline
was negatively correlated with daily stressor exposure in the CHR re-
mitted group and with life event exposure and trauma in the CHR
progressed group, but positively associated with daily stressor distress
in CHR individuals who later converted to psychosis; similarly, other
psychotropic medication was negatively correlated with daily stressor
exposure in the remitted group but positively correlated with daily
stressor and life event distress variables in the converter group. Current
cannabis use was associated positively with daily stressor exposure, life
event distress, and trauma in the control group and with life event
exposure in remitted and symptomatic groups.
The above analyses identified the following baseline factors as po-
tential confounders in the relationship between stress and cortisol: age,
sex, current antipsychotic use, current other psychotropic medication
use, and current cannabis use. However, owing to multicollinearity is-
sues (current antipsychotic and other psychotropic medication use were
strongly associated: χ2= 94.89, p<0.001), all models included anti-
psychotic use only as a covariate, with sensitivity analyses performed
using other psychotropic medication in place of antipsychotic use. We
were additionally concerned that controlling for current cannabis use
might obscure important relationships between stress and cortisol
(Miller and Chapman, 2001), given that recent evidence indicates that
stress can precipitate cannabis use in healthy and clinical samples
(Hyman and Sinha, 2009), and therefore included cannabis use as a
covariate in sensitivity analyses only.Ta
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3.3. Group differences in cortisol and psychosocial stressors
ANCOVAs (basal cortisol, continuous stress measures) and logistic
regression (trauma exposure) indicated significant main effects of group
status on basal cortisol (p= 0.013) and all stress measures (p <
0.001) after adjustment for age, sex, and antipsychotic use at baseline
(Table 3). Post-hoc comparisons (Sidak-corrected) indicated that only
CHR convertors were characterised by elevated basal cortisol compared
to controls (t=3.19, p=0.015), no other group differences were ob-
served. With regards to continuous stress measures (daily stressor ex-
posure and distress scores and life event exposure and distress scores),
all four CHR subgroups were characterised by significantly higher
scores relative to controls; for daily stressor exposure only, sympto-
matic, progressed, and converted groups also showed significantly
higher scores relative to remitted CHR youth. To confirm that the
greater exposure to life events observed in CHR subgroups was not
simply due to events that could be caused by illness, we additionally
compared groups on exposure to independent life events (data not
shown) and observed a significant main effect of group status
(F=10.86, p < 0.001). Post-hoc tests indicated that all CHR sub-
groups, except for the remitted group, reported increased exposure to
independent life events compared to controls. Finally, childhood
trauma was more common in all CHR groups compared to controls but
did not distinguish among CHR subgroups. All results were largely
unchanged when (a) cannabis use was included as an additional cov-
ariate and (b) other psychotropic medication use was additionally in-
cluded in place of antipsychotic medication, with the exception that
CHR remitted youth no longer showed significantly greater life event
exposure compared to controls.
3.4. Stressor-cortisol concordance by time lapse between assessments
In line with predictions, stressor-cortisol concordance varied
according to the lapse-of-time between assessments (see Fig. 1): When
acquired on the same day as saliva sampling, all stress measures showed
significant, positive correlations with cortisol (p< 0.05), except for life
event distress scores which were positively correlated but not sig-
nificantly. In contrast, stress measures were not significantly correlated
with cortisol in any other time-lapse category except for life event ex-
posure and cortisol which were positively associated when the lapse-of-
time was 31 days or longer. To account for the moderating effect of
time-lapse between assessments, interaction terms (stress*time-lapse)
were additionally included in subsequent regression models.
3.5. Stressor-cortisol concordance by clinical status at follow-up
Within-group linear regression analyses were performed (Table 4)
to examine stressor-cortisol concordance after adjustment for potential
confounders and the interaction between stressors and lapse-of-time
between assessments. Daily stressor distress was significantly associated
with cortisol in both controls (β=0.60, 95% CI: 0.12 to 1.08) and CHR
converters (β=0.91, 95% CI: 0.05 to 1.78). In the control group only,
greater life event exposure was associated with higher cortisol
( β=0.45, 95% CI: 0.08 to 0.83). In contrast, none of the stress mea-
sures were significantly associated with cortisol in the CHR remitted,
symptomatic, or progressed subgroups. Sensitivity analyses (data not
shown) indicated that there was no change to the overall pattern of
findings when cannabis use was included as an additional covariate or
when any psychotropic use was used in place of antipsychotic use.
Moreover, when we additionally adjusted all models for exposure to
dependent life events, results were unchanged. When Stβ coefficients
were pooled across all five stress measures, stressor-cortisol con-
cordance was highest in the CHR converted group (Stβ=0.26, 95% CI:
0.07 to 0.44), intermediate in controls (Stβ=0.15, 95% CI: 0.05 to
0.26), and lowest in the CHR progressed (Stβ=0.02, 95% CI: -0.11 to
0.15), symptomatic (St= 0.01, 95% CI: -0.11 to 0.12), and remitted
Fig. 1. Stressor-cortisol concordance by assessment time-lapse across the total sample. Correlations between psychosocial stressors and basal cortisol according to
lapse of time between stressor assessment and salivary cortisol collection (days).
Number of participants per time-lapse period for (a) daily stressor exposure/distress and cortisol: cortisol before stressor (n= 26), same day (n= 381), cortisol 1-10
days after (n=91), cortisol 11-30 days after (n=94), cortisol > 30 days after (n=70); (b) life event exposure/distress and cortisol: cortisol before stressor
(n=41), same day (n= 264), cortisol 1-10 days after (n= 152), cortisol 11-30 days after (n= 107), cortisol> 30 days after (n= 98); and (c) trauma exposure and
cortisol: cortisol before stressor (n= 28), same day (n=251), cortisol 1-10 days after (n=144), cortisol 11-30 days after (n=135), cortisol> 30 days after
(n=104).
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groups (Stβ=0.00, 95% CI: -0.13 to 0.13). Fig. 2 illustrates the pattern
of pooled stressor-cortisol across groups; whilst confidence intervals for
CHR converted and healthy control groups overlapped substantially,
the former were clearly distinguished from non-converted CHR sub-
groups (Cumming, 2009).
4. Discussion
The current study aimed to further characterise the nature of HPA
axis abnormalities among individuals at-risk for psychosis by examining
psychosocial stressors, basal cortisol, and the concordance between
these measures in a large sample of CHR youth categorised according to
clinical status at the two-year follow-up. In line with hypotheses, all
CHR groups were characterised by significantly greater psychosocial
stressor exposure and distress relative to healthy controls; however,
only those who converted to psychosis demonstrated elevated basal
cortisol levels. In contrast to expectations, whilst CHR converters
showed the greatest degree of stressor-cortisol concordance when
pooled across stressors, confidence intervals substantially overlapped
with the control group; moreover, the degree of concordance among
CHR youth who remitted, remained symptomatic, or whose positive
symptoms had progressed at follow-up was lower than that observed in
the control group.
After adjustment for potential confounders (including dependent
life events) and correction for multiple testing, only CHR converters
showed elevated basal cortisol relative to healthy controls. This finding
cannot be simply attributed to greater stressor exposure or distress
experienced by CHR converters relative to controls, as these features
characterised all CHR subgroups. This elevation might instead reflect an
amplification of the normative adolescent increase in cortisol secretion
(Apter et al., 1979; Marceau et al., 2015), or metabolic abnormalities
[more common among CHR youth (Cadenhead et al., 2019)], in-
dependent of stress exposure. Consistent with a recent meta-analysis
(Chaumette et al., 2016), pairwise comparisons showed that basal
cortisol levels did not distinguish CHR converters from CHR non-con-
verters. Whilst this suggests that within the CHR population, baseline
cortisol levels do not signal risk for psychosis transition, repeated
measurement of cortisol is needed to determine whether longitudinal
increases predict poorer outcomes in this group. Moreover, it should be
assumed that at 2-year follow-up there are some false negative cases in
the CHR non-converted groups (Ziermans et al., 2014), and thus dif-
ferences between converters and non-converters may increase with a
longer follow-up period.
We predicted that the degree of stressor-cortisol concordance, when
pooled across stressors, would increase in parallel with the level of
symptom expression at follow-up (i.e., controls < remitted <
symptomatic < progression of psychotic symptoms < converters).
Whilst the highest degree of concordance was indeed observed among
the CHR converters, the control group was intermediate, and pooled
beta coefficients in the three non-converted CHR subgroups were ap-
proximately zero (indicating no significant association between stressor
measures and basal cortisol). Moreover, confidence intervals for pooled
stressor-cortisol concordance estimates for all CHR subgroups (parti-
cularly the converter group) showed a high degree of overlap with the
control group (Fig. 2); it has been proposed that for many effect sizes,
confidence intervals overlapping by greater than 50% suggests that
effect sizes are not significantly different (Cumming, 2009). Thus, none
of the CHR subgroups showed significant hyper- or hypo-responsivity of
the HPA axis in response to psychosocial stressors encountered in the
natural environment when compared to controls. Stressor-cortisol
concordance was, however, substantially higher among CHR converters
compared to all other CHR subgroup (i.e., confidence intervals ap-
peared to overlap<50%). This finding is consistent with the only
previous study to examine the relationship between stressor-cortisol
concordance and outcome status in CHR individuals: Labad and col-
leagues similarly reported a moderate-to-strong (but not statisticallyTa
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significant) correlation between salivary cortisol and stressful life
events among those who later transitioned to psychosis, but only a
weak correlation in the non-transitioned CHR group (Labad et al.,
2015).
Overall, we found few significant associations between individual
stressors and basal cortisol across all groups (Table 4). Whilst this could
be due to the HPA axis and/or stress measures employed, previous
studies of at-risk youth which have used different measures have like-
wise found inconsistent associations between stress and cortisol (Cullen
et al., 2014b; Labad et al., 2015; Thompson et al., 2007). Similarly, in
healthy subjects, correlations between self-reported stress and cortisol
have not been observed (Cummins and Gevirtz, 1993; Vedhara et al.,
2003). Although the exact mechanisms underlying HPA responsivity to
stress are unknown (and likely complex), it has been demonstrated that
there are individual differences in responsivity that are partially de-
termined by genetic variants (e.g., FKBP5, CRHR1, NR3C1, NR3C2)
that modify the effect of acute and chronic stress/trauma on cortisol
levels in healthy adolescents and adults (Hartling et al., 2019; Starr
et al., 2019; Utge et al., 2018) and patients with psychosis (Mondelli
and Ciufolini, 2017). Thus, genetic and other vulnerability factors are
likely responsible for the different patterns of association between
stressors and cortisol that we observed across both individual stressor
types and, when pooled across stressors, CHR subgroups.
4.1. Limitations
Despite the large overall sample size, individual CHR subgroups
were notably smaller (particularly the converted group) thereby redu-
cing our ability to detect statistically significant associations between
psychosocial stressors and cortisol. Conversely, as we did not adjust for
multiple comparisons in our primary analyses examining stressor-cor-
tisol concordance, some significant associations may have arisen by
chance. However, we tested specific a priori hypotheses and were lar-
gely interested in the overall pattern of stressor-cortisol concordance
rather than statistical significance. Moreover, we adjusted for a range of
potential confounders which, had we not accounted for these variables,
would have led to spurious associations. A further limitation is that a
small proportion of participants (16%), experienced a long delay
(> two months) between baseline assessment visits, which led to a
large lapse-of-time between completion of psychosocial stressor as-
sessments and cortisol collection. Including these participants in the
analyses increased statistical power to test the moderating effect of
time-lapse on stressor-cortisol concordance. One major limitation is
that we examined only three stressor types. There are a range of other
stressors relevant to psychosis that might conceivably impact on HPA
axis function (e.g., urbanicity, neighbourhood cohesion, and socio-
economic deprivation); it is possible that examining a wider range of
stressors might yield different patterns of stressor-cortisol concordance
across CHR subgroups. Similarly, our findings are specific to basal
salivary cortisol, other measures (e.g., plasma cortisol or salivary
diurnal or awakening cortisol profiles) may have produced different
results.
Whilst the aim of our study was to examine the relationship be-
tween baseline features (psychosocial stressors, basal cortisol, and
stressor-cortisol concordance) and subsequent outcome (based on pro-
gression to psychosis), it is important to note that there are limitations
with this approach. First, we did not account psychosocial stressors and
other confounding factors/events that may have occurred in the time
between baseline and follow-up. Indeed, it is possible that stressor-
cortisol concordance at follow-up does in fact distinguish between CHR
subgroups, but that our measure at baseline was too distal to outcome.
Second, CHR individuals are at elevated risk for a wide range of psy-
chiatric disorders, particularly depression and anxiety (Addington
et al., 2017; Addington et al., 2019), and so worsening of prodromal
symptoms/transition to psychosis is only one of several potential out-
come measures, all of which will inevitably involve more false nega-
tives the shorter the follow-up period. Indeed, a recent study suggested
that well-established risk factors are better at predicting poor func-
tioning in CHR populations than transition to psychosis (Zhang et al.,
2019). The extent to which stressor-cortisol concordance at baseline is
associated with other non-psychotic disorders and functioning at
follow-up is therefore warranted.
4.2. Directions for future research
We assessed HPA axis function using basal salivary cortisol collected
in the laboratory, as it is more reliable and, unlike home sampling
methods, unlikely to be influenced by confounding factors such as ex-
ercise (Hill et al., 2008; Laceulle et al., 2015). However, meta-analytic
evidence indicates that the effect of chronic stress on cortisol varies
across cortisol measures; whilst diurnal (overall daily output) cortisol,
afternoon/evening cortisol, and the CARi (increase in cortisol following
awakening) are elevated following chronic stress, basal morning levels
are lower and the diurnal rhythm appears to be flatter (Chida and
Steptoe, 2009; Miller et al., 2007). Employing alternative cortisol
measures might therefore reveal different patterns of stressor-cortisol
concordance across CHR individuals and controls. Indeed, using a home
sampling procedure, Cullen and colleagues reported a negative corre-
lation between the CARi and negative life event distress in at-risk
children with a family history of schizophrenia but a positive
Fig. 2. Pooled standardised beta coefficients (with 95% confidence intervals), representing the magnit ude of stressor-cortisol concordance, by group status at follow-
up.
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correlation in typically-developing children (Cullen et al., 2014b),
whilst a study of adults found that diurnal cortisol was associated ne-
gatively with stressful life event exposure in first-episode psychosis
patients, most of whom were receiving antipsychotic medication, but
positively in controls (Mondelli et al., 2010). Thus, employing multiple
measures of cortisol may be more informative than basal cortisol alone
and enable the identification of dissociated relationships in at-risk in-
dividuals/psychosis patients and healthy controls.
Cortisol output is not, however, the only method of assessing HPA
axis function. In addition to endocrine measurement (which extends to
other HPA-axis hormones, e.g., adrenocorticotropic hormone) neuroi-
maging can be used to determine pituitary and hippocampal volume
(key structures involved in mediating HPA axis function) and density,
distribution and/or affinity of glucocorticoid/mineralocorticoid re-
ceptors. The latter is particularly important as these receptors mediate
the effects of glucocorticoids on cellular targets. As a related point,
future studies are warranted to investigate glucocorticoid sensitisation
(i.e., the responsiveness to increased glucocorticoids over time), in CHR
youth, as this may have implications not only for the HPA axis, but also
the immune system (Cain and Cidlowski, 2017), and dopamine levels
(Lefevre et al., 2017). Thus, studies employing multiple methodological
approaches, including genetic profiling, neuroimaging, and endocrine
measurement, may be needed to adequately investigate the extent to
which individuals at-risk for psychosis are characterised by increased
HPA axis sensitivity.
Our findings have other implications for future research examining
HPA axis responsivity in at-risk individuals. First, we observed that the
lapse-of-time between completion of stress measures and cortisol col-
lection moderated stressor-cortisol concordance (with minor excep-
tions, significant relationships were observed only when measures were
collected on the same day). Whilst we anticipated this pattern for daily
stressors occurring within the past 24 hours, the findings for life events
and childhood trauma were not predicted as these events did not occur
on the day of measurement. It is plausible that reporting these events in
the research environment is itself a stressful experience for some par-
ticipants, and that it elicits a cortisol elevation and thus a relationship
between stressor exposure and cortisol. These findings highlight the
importance of adjusting for the interaction between stressors and time-
lapse between assessments when examining stressor-cortisol con-
cordance. Second, participant sex was identified as a potential con-
founder. The updated neural diathesis-stress model noted sex differ-
ences to be an important area for future research (Pruessner et al.,
2017), whilst it was beyond the scope of the current study to explore
whether sex modified the degree of stressor-cortisol concordance, fu-
ture studies should investigate this possibility. Finally, whilst we de-
fined CHR outcome status on the basis of attenuated positive symptoms
and transition to psychosis, as noted above, there has been recent ac-
knowledgement of the need to examine a broader range of outcomes,
including, levels of social and role functioning, non-psychotic disorders,
and negative symptoms (Addington et al., 2011; Yung et al., 2019).
Future studies might therefore examine whether stressor-cortisol con-
cordance is associated with these outcomes at follow-up.
4.3. Conclusions
The original neural diathesis-stress model of schizophrenia (Walker
and Diforio, 1997) and subsequent revisions of this hypothesis
(Pruessner et al., 2017; Walker et al., 2008) hypothesized that heigh-
tened HPA axis activity among those at elevated risk for psychosis could
be stress-induced, a manifestation of hippocampal dysfunction or glu-
cocorticoid receptor abnormalities, or genetically determined. In the
current study, we tested the first of these possibilities and conclude that
the elevation in basal cortisol levels among CHR converters is not
simply due to increased psychosocial stressor exposure and distress, as
the latter was common to all CHR subgroups. Our analyses did, how-
ever, show that naturally-occurring psychosocial stressors were more
strongly associated with basal cortisol levels in CHR converters com-
pared to CHR non-converters (perhaps driven by genetic factors), al-
though the degree of concordance did not appear to differ significantly
in converters and healthy controls. Given the novelty of this in-
vestigation, this pattern of findings warrants further investigation in
other at-risk populations.
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